#384 - Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer's prevention
<p><a href= "https://peterattiamd.com/obicetrapib/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=260316-pod-obicetrapib&utm_content=260316-pod-obicetrapib-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subscribe/?utm_source=podcast-feed&%20obicetrapib%20=referral&utm_campaign=260316-pod-obicetrapib&utm_content=260316-pod-obicetrapib-podfeed"> Become a Member to Receive Exclusive Content</a></p> <p><a href= "https://peterattiamd.com/newsletter/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=260316-pod-obicetrapib&utm_content=260316-pod-obicetrapib-podfeed"> Sign Up to Receive Peter's Weekly Newsletter</a></p> <p>In this special episode, Peter takes a deep dive into obicetrapib, an investigational drug that has captured his attention and renewed interest in an entire class of therapies known as CETP inhibitors. He explains what obicetrapib is and how it works, revisits the history of CETP inhibitors and why …
Αυτό το επεισόδιο δεν έχει μεταγραφτεί ακόμα.
Χρησιμοποιήστε STT.ai για να μεταγράψετε αυτό το επεισόδιο με AI. Αποκτήστε ακριβές κείμενο με ανίχνευση ηχείων, χρονοσφραγίσεις, και εξαγωγή σε πολλαπλές μορφές.